Becton Dickinson Net Worth 2010-2022 | BDX

Interactive chart of historical net worth (market cap) for Becton Dickinson (BDX) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Becton Dickinson net worth as of June 23, 2022 is $69.14B.
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $69.140B $20.248B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $45.179B 13.28
AmerisourceBergen (ABC) United States $30.289B 13.97
Laboratory Of America Holdings (LH) United States $22.213B 9.28
West Pharmaceutical Services (WST) United States $22.141B 33.74
Cooper (COO) United States $15.181B 23.36
Cardinal Health (CAH) United States $14.444B 11.09
CONMED (CNMD) United States $2.694B 27.82
Invacare (IVC) United States $0.053B 0.00